591 related articles for article (PubMed ID: 15358572)
1. Chromosome aberrations in Raynaud's phenomenon.
Porciello G; Scarpato R; Storino F; Migliore L; Ferri C; Cagetti F; Morozzi G; Bellisai F; Marcolongo R; Galeazzi M
Eur J Dermatol; 2004; 14(5):327-31. PubMed ID: 15358572
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon.
Porciello G; Scarpato R; Ferri C; Storino F; Cagetti F; Morozzi G; Bellisai F; Migliore L; Marcolongo R; Galeazzi M
J Rheumatol; 2003 Jun; 30(6):1244-7. PubMed ID: 12784397
[TBL] [Abstract][Full Text] [Related]
3. [Chromosome aberrations, valued as frequency of spontaneous micronuclei, in subjects with suspected presclerodermic Raynaud's phenomenon].
Porciello G; Scarpato R; Storino F; Cagetti F; Bellisai F; Morozzi G; Marcolongo R; Migliore L; Ferri C; Galeazzi M
Reumatismo; 2003; 55(1):28-33. PubMed ID: 12649697
[TBL] [Abstract][Full Text] [Related]
4. Association between Raynaud's phenomenon and migraine in a random population of hospital employees.
O'Keeffe ST; Tsapatsaris NP; Beetham WP
J Rheumatol; 1993 Jul; 20(7):1187-8. PubMed ID: 8371215
[TBL] [Abstract][Full Text] [Related]
5. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
Hostein J; Bost R; Carpentier P; Franco A; Fournet J
Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
[TBL] [Abstract][Full Text] [Related]
6. Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon.
Pancera P; Sansone S; Presciuttini B; Montagna L; Cerù S; Lunardi C; Lechi A
Clin Sci (Lond); 1999 Jan; 96(1):49-57. PubMed ID: 9857106
[TBL] [Abstract][Full Text] [Related]
7. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
Stoyneva Z
Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
[TBL] [Abstract][Full Text] [Related]
8. [The determination of the thermal threshold in subjects with Raynaud's disease. A preliminary report of 2 clinical cases].
Luca S; Romeo S
Minerva Cardioangiol; 1999 Jun; 47(6):213-7. PubMed ID: 10522147
[TBL] [Abstract][Full Text] [Related]
9. Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon.
Schuhfried O; Vacariu G; Lang T; Korpan M; Kiener HP; Fialka-Moser V
Arch Phys Med Rehabil; 2000 Apr; 81(4):495-9. PubMed ID: 10768542
[TBL] [Abstract][Full Text] [Related]
10. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
Rychlik-Golema W; Mastej K; Adamiec R
Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
[TBL] [Abstract][Full Text] [Related]
11. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
Colakoğlu M; Cobankara V; Akpolat T
Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
[TBL] [Abstract][Full Text] [Related]
12. [The natural course of Raynaud's phenomenon].
Clavijo F; Krahenbuhl B
Schweiz Med Wochenschr; 1981 Dec; 111(51):2023-7. PubMed ID: 7313657
[TBL] [Abstract][Full Text] [Related]
13. Lack of habituation of the pattern of cardiovascular response evoked by sound in subjects with primary Raynaud's disease.
Edwards CM; Marshall JM; Pugh M
Clin Sci (Lond); 1998 Sep; 95(3):249-60. PubMed ID: 9730843
[TBL] [Abstract][Full Text] [Related]
14. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
[TBL] [Abstract][Full Text] [Related]
15. [Raynaud's phenomenon after chemotherapy. Apropos of 3 cases].
Adoue D; Arlet P; Vilain C; Le Tallec Y; Bonafé JL; de Lafontan B
Ann Dermatol Venereol; 1985; 112(2):151-5. PubMed ID: 2408534
[TBL] [Abstract][Full Text] [Related]
16. Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenon.
van der Maulen J; Wouda AA; Mandema E; The TH
Clin Exp Immunol; 1979 Jan; 35(1):62-6. PubMed ID: 428147
[TBL] [Abstract][Full Text] [Related]
17. Linear and nonlinear analysis of blood flow in healthy subjects and in subjects with Raynaud's phenomenon.
Stefanovska A; Leger P; Bracic M; Bracic T; Bendayan P; Boccalon H
Technol Health Care; 1999; 7(2-3):225-41. PubMed ID: 10463311
[TBL] [Abstract][Full Text] [Related]
18. [Antiendothelial antibodies in systemic scleroderma and Raynaud's disease].
Salozhin KV; Shcherbakov AB; Nasonov EL; Kolesova NV; Romanov IuA; Guseva NG
Ter Arkh; 1995; 67(5):54-7. PubMed ID: 7638782
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
Fries R; Shariat K; von Wilmowsky H; Böhm M
Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
[TBL] [Abstract][Full Text] [Related]
20. The 3p21.1-p21.3 hereditary vascular retinopathy locus increases the risk for Raynaud's phenomenon and migraine.
Hottenga JJ; Vanmolkot KR; Kors EE; Kheradmand Kia S; de Jong PT; Haan J; Terwindt GM; Frants RR; Ferrari MD; van den Maagdenberg AM
Cephalalgia; 2005 Dec; 25(12):1168-72. PubMed ID: 16305605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
